Head-To-Head Survey: Semler Scientific (SMLR) & Its Rivals

Semler Scientific (NASDAQ:SMLRGet Free Report) is one of 71 public companies in the “Electromedical equipment” industry, but how does it compare to its peers? We will compare Semler Scientific to similar businesses based on the strength of its dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Semler Scientific and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Semler Scientific 0 1 0 0 2.00
Semler Scientific Competitors 164 685 1887 94 2.68

Semler Scientific presently has a consensus target price of $45.00, indicating a potential upside of 62.87%. As a group, “Electromedical equipment” companies have a potential upside of 58.03%. Given Semler Scientific’s higher probable upside, equities analysts plainly believe Semler Scientific is more favorable than its peers.

Earnings & Valuation

This table compares Semler Scientific and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Semler Scientific $56.69 million $14.32 million 12.28
Semler Scientific Competitors $1.10 billion $94.75 million 3.15

Semler Scientific’s peers have higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Volatility & Risk

Semler Scientific has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Semler Scientific’s peers have a beta of 13.09, meaning that their average stock price is 1,209% more volatile than the S&P 500.

Insider and Institutional Ownership

93.6% of Semler Scientific shares are held by institutional investors. Comparatively, 46.9% of shares of all “Electromedical equipment” companies are held by institutional investors. 13.0% of Semler Scientific shares are held by insiders. Comparatively, 10.7% of shares of all “Electromedical equipment” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.


This table compares Semler Scientific and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Semler Scientific 27.44% 30.26% 26.34%
Semler Scientific Competitors -436.73% -126.98% -36.01%


Semler Scientific beats its peers on 7 of the 13 factors compared.

About Semler Scientific

(Get Free Report)

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups, long-term care, or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.